Related references
Note: Only part of the references are listed.Brain metastases in metastatic cancer: a review of recent advances in systemic therapies
Ariane Steindl et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2021)
Role of radiotherapy in the management of brain metastases of NSCLC - Decision criteria in clinical routine
Markus Glatzer et al.
RADIOTHERAPY AND ONCOLOGY (2021)
Management of multiple brain metastases: a patterns of care survey within the German Society for Radiation Oncology
Johannes Kraft et al.
JOURNAL OF NEURO-ONCOLOGY (2021)
Chronic obstructive pulmonary disease and lung cancer: access to palliative care, emergency room visits and hospital deaths
Peter Strang et al.
BMC PULMONARY MEDICINE (2021)
Overall survival after initial radiotherapy for brain metastases; a population based study of 2140 patients with non-small cell lung cancer
Astrid Telhaug Karlsson et al.
ACTA ONCOLOGICA (2021)
EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours
E. Le Rhun et al.
ANNALS OF ONCOLOGY (2021)
Health care utilization at end of life among patients with lung or pancreatic cancer. Comparison between two Swedish cohorts
Helena Ullgren et al.
PLOS ONE (2021)
Epidemiology of brain metastases and leptomeningeal disease
Nayan Lamba et al.
NEURO-ONCOLOGY (2021)
Current approaches to the management of brain metastases
John H. Suh et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Systemic treatment of brain metastases in non-small cell lung cancer
Simon Page et al.
EUROPEAN JOURNAL OF CANCER (2020)
Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient
Paul W. Sperduto et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Impact of variation in cancer registration practice on observed international cancer survival differences between International Cancer Benchmarking Partnership (ICBP) jurisdictions
Michael Eden et al.
CANCER EPIDEMIOLOGY (2019)
Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer A Review
Kathryn C. Arbour et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Death at home: predictive factors in a medical home care unit
Martina Rasch-Westin et al.
BMJ Supportive & Palliative Care (2019)
Management of Brain Metastases in Non-Small-Cell Lung Cancer
Vinicius Ernani et al.
JOURNAL OF ONCOLOGY PRACTICE (2019)
Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy
Lais Osmani et al.
SEMINARS IN CANCER BIOLOGY (2018)
Prognostic factors affecting survival after whole brain radiotherapy in patients with brain metastasized lung cancer
Georgios Tsakonas et al.
ACTA ONCOLOGICA (2018)
Lung cancer-associated brain metastasis: Molecular mechanisms and therapeutic options
Meysam Yousefi et al.
CELLULAR ONCOLOGY (2017)
Association of Molecular Marker Status With Graded Prognostic Assessment of Lung Cancer With Brain Metastases
John H. Suh
JAMA ONCOLOGY (2017)
Estimating Survival in Patients With Lung Cancer and Brain Metastases An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
Paul W. Sperduto et al.
JAMA ONCOLOGY (2017)
End-of-life care: Where do cancer patients want to die? A systematic review
Jonas Nilsson et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2017)
The Brain Metastases Symptom Checklist as a novel tool for symptom measurement in patients with brain metastases undergoing whole-brain radiotherapy
D. Rodin et al.
CURRENT ONCOLOGY (2016)
The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases
Paul W. Sperduto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial
Paula Mulvenna et al.
LANCET (2016)
Patterns of Smoking and Snus Use in Sweden: Implications for Public Health
Lars Ramstroem et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2016)
Comparison of ECOG/WHO Performance Status and ASA Score as a Measure of Functional Status
Jane Young et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2015)
Patient selection for whole brain radiotherapy (WBRT) in a large lung cancer cohort: Impact of a new Dutch guideline on brain metastases
Lizza E. L. Hendriks et al.
ACTA ONCOLOGICA (2014)
Radiotherapy versus best supportive care in patients with brain metastases and adverse prognostic factors
Carsten Nieder et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
Paul W. Sperduto et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline
May N. Tsao et al.
PRACTICAL RADIATION ONCOLOGY (2012)
A new prognostic index and comparison to three other indices for patients with brain metastases: An analysis of 1,960 patients in the RTOG database
Paul W. Sperduto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Brain metastases: epidemiology and pathophysiology
IT Gavrilovic et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
Share Paper
